CROI 2010 -

Program at-a-Glance

Time	Day 1	Day 2	Day 3	Day 4
Time	Tuesday February 16	Wednesday February 17	Thursday February 18	Friday February 19
8-8:30am	8 am-12 nProgram Committee Workshop for New Investigators and Trainees 12:15-1 pmPC Lunch for Award/Scholarship Recipients 12 n-2 pmFrontiers in Lab Science Workshop	PlenaryPutting the 'C' in MTCT–Saving KidsElaine AbramsColumbia Univ, Mailman Sch of Publ Hlth, New York, NY, US	PlenaryThe US Epidemic–Disparities in HIV CareKim SmithRush Med Coll, Chicago, IL, US	Plenary TBD
8:30-9am		PlenaryVirus Assembly and ReleaseHans-Georg KrausslichUniv of Heidelberg, Germany	PlenaryPathogenic vs Nonpathogenic Retrovirus InfectionsGuido SilvestriUniv of Pennsylvania, Philadelphia, US	PlenaryHepatitis C Virus Entry: Unlocking the DoorCharles RiceThe Rockefeller Univ, New York, NY, US
9-9:30am		Break	Break	Break
9:30am-12n		Oral Abstract Sessions Developments in Molecular Epidemiology of XMRV, SIV, and HIV Testing and Transmission What’s New in Immunopathogenesis Advances in ART	Oral Abstract Sessions HIV Vaccines: The Path Forward Antiretroviral-based Prevention: Exposure and Efficacy New Resistance Mechanisms and Detection Methods New Insights into Retroviral Pathogenesis TB: Prevention and Treatment Progress and Problems in ART Rollout	Oral Abstract Sessions New Insights into Transmission and Acute Infection Developments in Viral Restrictions, Co-factors and Virus–Host Cell Treatment Outcomes in Women Hepatitis C: Transmission, Outcomes, and Treatment
12n-1pm		Lunch	Lunch	Lunch
1-2pm		Themed Discussions NeuroAIDS Treatment Issues and Controversies What Monkey Models Can Teach Us about HIV Infection Prediction of HIV Co-receptor Use Hepatitis B and C: The Next Chapter in the Management of HIV in Resource-limited Countries Got Milk? Vitamin D Deficiency Prevalence and Associations	Themed Discussions Impact of KIR/HLA on HIV Infection Improving Estimates of HIV-1 Incidence Viral Co-factors and Cellular Restrictions HIV Drug Resistance in Breast-feeding Infants Exposed to ART Progression of Atherosclerosis: Role of Inflammation and T Cell Activation	Themed Discussions Antiretroviral Agent Penetration into Genital Secretions NK Cells and ADCC: Linking Innate and Adaptive Immunity Impact of Treatment Intensification on HIV Reservoirs and Immune Activation Renal Disease: Mechanisms and Outcomes
2-4pm	2-2:30 pm Break	Poster Abstract Sessions	Poster Abstract Sessions	Poster Abstract Sessions
2-4pm	2:30-5 pmOpening SymposiumGuiding the Global Response Implementation Strategy RoundtableThe Future of PEPFAREric GoosbyUS Dept of State, Washington, DC	Poster Abstract Sessions	Poster Abstract Sessions	Poster Abstract Sessions
4-6pm		Symposia New Strategies for a Changing Epidemic Targeting the HIV-1 Envelope Glycoprotein Pathogenesis and Clinical Management of Complications Oral Abstract Session Emerging Epidemiology and Therapy of AIDS-related Malignancies	Symposia Understanding the Variability in Drug Response Challenges in HIV Prevention HIV Replication: In and Out of the Cell Oral Abstract Session Long-term Complications: Hearts and Bones	Symposia New Insights into Mechanisms of T Cell Protection The Future of HIV Therapeutic Research–The Treatment Agenda Oral Abstract Session Neuropathogenesis: Clinical Correlates and Impact of ART
	5-5:30 pm Break
	Research Strategy PlenaryThe US HIV Research Agenda-Vision for NIAIDAnthony FauciNIAID, NIH, Bethesda, MD, US
6-7pm
	6:15-6:30 pm Break
	Opening Plenaries SessionBernard Fields LectureGeorge ShawUniv of Alabama at Birmingham, US N’Galy-Mann LectureSuniti SolomonYR Gaitonde Ctr for AIDS Res and Ed, Chennai, India
7-8pm
8-9pm	Welcome Reception

Time	Wednesday, February 17	Thursday, February 18	Friday, February 19
7am-7pm	Poster Halls open 7 am to 7 pm Monday through Wednesday All posters will be available for viewing for the duration of the conference
2-4 pm	Poster Sessions
	Cellular Restrictions: APOBEC Cellular Restrictions: TRIM5 and Novel Factors Cellular Restrictions: Tetherin and VPU Viral Co-factors and Cellular Restrictions < also a Themed Discussion on Thursday > HIV Evolution in vivo Evolution of HIV Co-receptor Usage CTL Epitopes and Immune Control Novel Insights into HLA Alleles and CD8 T Cell Control New Factors Associated with CD8 T Cell Function Modulating CD8 T Cells to Control Virus Replication New Insights from Neuroimaging Mechanisms of Neuropathogenesis Molecular Epidemiology: Evolution, Subtype Distribution, and Viral Diversity Plasma HIV RNA Monitoring: Suppression and Persistent Viremia Keys to Successful Outcomes on ART Activity and Escape from HIV Entry Inhibitors Evaluation of Sample Storage Technology Prevalence and Consequences of Transmitted Drug Resistance Mechanisms of Activity and Failure of ART Pharmacokinetics and Pharmacodynamics of Entry Inhibitors Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of NRTI and NNRTI Hepatitis B: Epidemiology and Prevention Hepatitis B: Treatment Acute Hepatitis C Infection Hepatitis C: Predictors and Determinants of Response to Therapy and Its Complications Hepatitis C Therapy: ART Interactions Cardiovascular Disease: Pathogenesis Predictors of Cardiovascular Risk and Carotid Intima-Media Thickness Progression of Atherosclerosis: Role of Inflammation and T Cell Activation < also a Themed Discussion on Thursday > Cardiovascular Events: Assessment, Predictors, and Outcomes Abacavir and Cardiovascular Disease: Search for a Mechanism Dyslipidemia and Fat Changes: ART Effects Fat: Pathogenesis, Measurement, and Interventions Complications of HIV Disease: Epidemiology and Predictors of Mortality Complications: Role of Genetic Markers and Mitochondrial DNA Immune Responses to KSHV/HHV-8 Clostridium difficile, Leprosy, Leishmania, and Cryptococcal Disease Influenza: Incidence and Prevention Pneumococcal Vaccine Responses Neurodevelopmental Outcomes in Children Metabolic Complications and Toxicities in Children ART Pharmacokinetics, Safety, and Efficacy in Children Factors Influencing PMTCT Implementation Persistence of Resistance and Treatment Outcomes in Women after Single Dose Nevirapine HIV Drug Resistance in Breast-feeding Infants Exposed to ART < also a Themed Discussion on Thursday > Improving Estimates of HIV-1 Incidence < also a Themed Discussion on Thursday > Preclinical and Animal Studies of Microbicides/PrEP New Insights on Male Circumcision Insights into Post-exposure Prophylaxis New HIV Prevention Strategies and Modeling of Impact Risk Behaviors for HIV Infection HIV Disease Progression	New Insights into Virus Replication: Co-factors and Virus Entry Virus–Host Cell Interaction: Studies on Macrophages Therapeutic Strategies for Nef Viral Decay Dynamics with ART Impact of Treatment Intensification on HIV Reservoirs and Immune Activation < also a Themed Discussion on Friday > HIV–Cell Interaction in vivo Determinants of Slow Progression of HIV Disease CD4 T Cell Functions and Immune Recovery What Monkey Models Can Teach Us about HIV Infection < also a Themed Discussion on Wednesday > NK Cells and ADCC: Linking Innate and Adaptive Immunity < also a Themed Discussion on Friday > New Markers of Immune Dysfunction and Recovery Novel Approaches to Modulate CD4 Cell Infection and Survival Neuropathy and Locomotor Disorder Infection and Immune Activation of CNS Compartments Molecular Epidemiology: Dual/Superinfection and Viral Recombinants Host Genetics of HIV Infection: Novel Co-factors, Risk Alleles, and Biomarkers Insights into Factors Affecting Acute HIV Infection Biomarkers and Treatment during Acute HIV Infection ART: New Agents and Novel Approaches Prediction of HIV Co-receptor Use < also a Themed Discussion on Wednesday > Resistance to Reverse Transcriptase Inhibitors Changing Prevalence of Multidrug Resistance Adherence–Drug Resistance Relationships Antiretroviral Agent Penetration into Genital Secretions < also a Themed Discussion on Friday > Hepatitis C: Metabolic and Vascular Interactions Hepatitis Immunology Predictors of Liver Fibrosis Hepatitis: Cirrhosis, Cancer, and Transplant Renal Disease: Mechanisms and Outcomes < also a Themed Discussion on Friday > Renal Disease: Incidence Outcomes and Mechanisms of Disease Risk Factors and Outcomes for AIDS-related Malignancies OI Prophylaxis IRIS: Incidence and Pathogenesis Malaria and HIV Response to ART in Resource-limited Countries Survival of HIV-infected Children in Africa Response to First-line ART in Children HIV Drug Resistance after Treatment Failure in Children Screening for HIV and TB Co-infection in Adolescents Impact of ART on Disease Pathogenesis in Children Antiretroviral Regimens, Viral Response, and MTCT Outcomes TB Screening and Impact in PMTCT Breast Milk Shedding of HIV and ART Impact New Insights into Molecular Mechanisms of MTCT Infant Outcome after Prenatal ART Exposure ART Outcomes among Women Contraception Use and Drug Interactions New HIV–1 RNA Assays and Reagents Identifying Persons at Risk for HIV Infection ART and Transmission	Virus–Host Cell Interaction: Impact of Virus on Host Cell Processes New Insights into Virus Replication: Integration, Assembly, and Viral Latency HIV Reservoirs Biomarkers of HIV Disease and Death Exposed Uninfected Individuals: What's New New Discoveries on Neutralizing Antibodies New Information on Dendritic Cells and HIV Role of the Gut Mucosa in HIV Immunopathogenesis Neutralizing Antibodies: Induction and Impact New Approaches to Mucosal Vaccination Neurocognitive Predictors and Co-morbidities in the ART Era NeuroAIDS Treatment Issues and Controversies < also a Themed Discussion on Wednesday > Molecular Epidemiology: Analysis of HIV Transmission Patterns Impact of KIR/HLA on HIV Infection < also a Themed Discussion on Thursday > Molecular Characterization of HIV Transmission and Acute Infection HIV Transmission and the Mucosa First Line of Defense: ART in Resource-limited Settings Life Expectancy on ART Resistance to Integrase Inhibitors Resistance to Protease and Maturation Inhibitors Detection of Minority Resistance Mutations Genotypic Assays for HIV Drug Resistance Phenotypic Assays for HIV Drug Resistance Strategies to Prevent HIV Drug Resistance Pharmacokinetics and Drug Interactions of Integrase Inhibitors Pharmacokinetics and Drug Interactions of Protease Inhibitors Hepatitis C: Epidemiology and Outcomes Hepatitis B and C: The Next Chapter in the Management of HIV in Resource-limited Countries < also a Themed Discussion on Wednesday > Hepatitis E and GBV-C Bone Disease: Risk Factors Got Milk? Vitamin D Deficiency Prevalence and Associations < also a Themed Discussion on Wednesday > Cervical and Anal Cancer: Screening, Prevalence, and Therapy Diagnostics: TB and Pneumocystis carinii Pneumonia TB Screening: Strategies and Diagnostic Testing TB Incidence: Impact of ART TB Outcomes: HIV, ART, and Immune Mechanisms Multidrug-resistant TB Treatment and Retention in Resource-limited Countries Malnutrition and Nutritional Supplementation: Outcomes HIV-related Complications and Co-infections in Children Response to Protective Vaccines in Children Immune Response to Perinatal HIV Infection Diagnostics for HIV Infection in Exposed Infants ART Pharmacokinetics and Safety during Pregnancy and Breast Feeding New Diagnostic Technologies Identifying HIV Incidence Identifying HIV Infection Mental Health, Substance Abuse, and HIV in Resource-limited Countries HPV and HIV HIV and STD